Rocket Lab SEC Filings

Peter Beck, President, CEO, and Chairman of Rocket Lab USA, via his family trust (Equatorial Trust), converted 5,000,000 shares of Series A Convertible Participating Preferred Stock into 5,000,000 shares of Common Stock on June 17, 2025. Beck holds 789,373 shares directly. This is neutral as it prepares shares for delivery to a broker under a newly adopted Rule 10b5-1 trading plan for sales starting September 15, 2025.

Arjun Kampani, Senior Vice President, General Counsel and Secretary, sold 5,194 shares of RKLB common stock on June 9, 2025, at $30 per share. The transaction was automatic under a Rule 10b5-1 plan adopted December 12, 2024. Neutral signal due to pre-scheduled nature.

Frank Klein, Chief Operations Officer, sold 2,546 shares of RKLB common stock at $30/share on 06/09/2025. The sale was automatic under a Rule 10b5-1 plan adopted 12/13/2024. Neutral signal due to pre-planned nature.

This Form 15 certifies termination of registration under Section 12(g) for Rocket Lab USA, Inc. following a May 23, 2025 holding company reorganization. Rocket Lab USA became a wholly owned subsidiary of new parent Rocket Lab Corp, which assumes successor reporting obligations. The filing affects only the old entity's duties and notes one record holder.

Rocket Lab announced its 2025 annual stockholder meeting on August 27, 2025, more than 30 days from last year's date. Deadlines for Rule 14a-8 proposals and Bylaw director nominations are both June 19, 2025, at the Long Beach headquarters. No financial impact disclosed.

Rocket Lab Corporation officer Frank Klein filed Form 144 on June 9, 2025, to sell 2,546 common shares acquired via RSUs on May 22, 2025, with an aggregate market value of $73,630. The sale is pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2024. Klein discloses recent sales totaling ~97,660 shares for ~$2.17M in the past three months, all routine and non-indicative of adverse information.

Rocket Lab officer Arjun Kampani filed Form 144 on June 9, 2025, notifying of intent to sell 5,194 common shares acquired via RSUs vested May 22, 2025, with aggregate value $150,210.48. Sales are pursuant to a Rule 10b5-1 plan adopted December 12, 2024. The filing discloses recent sales totaling ~70,422 shares for ~$1.7M in the past three months, all planned.

Adam C. Spice, Chief Financial Officer, sold 63,444 shares of Common Stock on 05/30/2025 at a weighted average price of $26.6589. The transaction was an automatic 'sell-to-cover' to satisfy tax withholding obligations upon vesting of restricted stock units, leaving him with 1,133,235 shares directly owned. This is a neutral signal as it was non-discretionary.

Arjun Kampani, Senior Vice President, General Counsel and Secretary at Rocket Lab USA, sold 28,988 shares on 05/30/2025 as automatic sell-to-cover for RSU vesting taxes and 5,194 shares on 06/02/2025 pursuant to a Rule 10b5-1 plan adopted in December 2024. Total value approximately $911K at weighted average prices around $26.60. Neutral signal due to non-discretionary, pre-planned nature.

Frank Klein, Chief Operations Officer of Rocket Lab USA Inc., sold 44,885 shares on May 30, 2025, as sell-to-cover for RSU vesting taxes, and 1,818 shares on June 2, 2025, pursuant to a Rule 10b5-1 trading plan adopted in December 2024. Total value approximately $1.24 million at weighted average prices around $26.60. Neutral signal due to automatic, non-discretionary nature.